Automatic Clotting Timer Systems Market

Well-Suited System for Point-of-Care Testing

Automatic clotting timer system is a coagulation instrument designed to determine coagulation endpoints in whole blood, plasma samples and citrated whole blood. Automatic clotting timer systems are well appropriate for all point-of-care testing situations. They offer flexibility in cardiovascular and vascular surgery, cardiac catheterization laboratories, hemodialysis units and critical care units.

Automatic clotting timer systems are available in variety of models to monitor heparin at proper level. Automatic clotting timer systems measure high range activated clotting time (HR-ACT), Low range activated clotting time (LR- ACT), Heparinase test (HC) and recalcified activate clotting time. These systems are also used for measuring citrate prothrombin time, prothrombin time, activated partial thromboplastin time, and citrated partial thromboplastin time. These all tests are run quickly, easily and reliably by automatic clotting timer systems. The demand for automatic clotting timer system will increase due to point-of-care testing in surgical procedures.

Many of automatic clotting timer systems are microprocessor-controlled systems. The clotting time results are displayed on a screen. Automated clotting timer systems provide long-term data storage and retrieval with access of previous patient’s data. Test outcomes are stored in systems on which test will accomplished. Automated clotting timer systems have availability to transfer data externally and enhance the systems flexibility.

Requirement of Clotting Timer in Cardiopulmonary Bypass

Automated clotting timer systems are used for both bedside and intraoperative monitoring of heparin therapy in setting of invasive or operative procedures. The automated clotting timer systems are mostly used in dialysis, cardiac catheterization, intra-aortic balloon pumping, angiography, percutaneous coronary intervention (PCI), extracorporeal membrane oxygenation (ECMO), vascular surgery valve replacement, and cardiopulmonary bypass graft surgery. Point-of-care testing is must needed in cardiac surgeries. For running cardiac bypass surgery accurate blood diagnosis results are required. Automated clotting timer systems can be used in all the phases of preoperative surgery.

Clotting time test is most commonly used test in haematology testing. Preoperative blood test reduces both perioperative blood loss and rate of transfusion of allogeneic blood products in haemostatic procedures. Automated clotting timer systems are basically based on algorithm-based haemostatic treatment based on viscoelastic point-of-care coagulation testing. Automated clotting timer systems are beneficial and must needed in surgical processes. These systems analyze how quickly small blood vessels in your skin close up and stop bleeding.

Automatic Clotting Timer Systems Market Assessment by Product Type

Factors Driving the Automatic Clotting Timer Systems Market

The global market for automatic clotting timer systems is driven by factors such as increasing adoption of automated haemostasis instrument, technological advancements, and high sensitivity of point-of-care testing. Increasing blood-related disorders, high incidence of cardiovascular disorders and rising geriatric population are other factors that propel the growth of the global automatic clotting timer systems market. Factors such as systems portability, connectivity, accuracy, timely results, and ease of use have increased the demand for automatic clotting timer systems.

Slow adoption of advanced automatic clotting timer systems in emerging economies and high cost of fully automated systems will hamper the growth of automatic clotting timer systems market.

Regional Market Outlook

North America will continue to dominate the global market due to the availability of advanced technologies and more number of clinical laboratory tests. Europe is expected to hold second large market share in the global automatic clotting timer systems market due to growing prevalence of chronic diseases.

Asia Pacific will provide growth opportunities to the players in the automatic clotting timer systems market due to number of factors such as presence of large geriatric population, increasing healthcare infrastructure and increasing funding and investment towards the automated haemostasis products.

Competition Outlook

Examples of some of the players identified in the global automatic clotting timer systems market are F. Hoffmann-La Roche Ltd., Medtronic, Thermo Fisher Scientific Inc., Siemens Healthcare, Nihon Kohden Corporation, Werfen Life Group, S.A., Alere Inc., Diagnostica Stago S.A.S., International Technidyne, Edison, NJ, Sysmex Corporation, Helena Laboratories, etc.

Majority of automatic clotting timer systems are available as point-of-care tests. However, the point-of-care automatic clotting timer systems market offers a global opportunity to its manufacturers, as they are the common tests performed globally. Increasing usage of these systems has created ample opportunities for the manufactures to come up with more effective solutions over the forecast period.

Small-Scale Manufacturers/Providers

• International Technidyne, Edison, NJ
• Sysmex Corporation
• Helena Laboratories

Medium-Scale Manufacturers/Providers

• Nihon Kohden Corporation
• Werfen Life Group, S.A.
• Alere Inc.
• Diagnostica Stago S.A.S.

Large-Scale Manufacturers/Providers

• F. Hoffmann-La Roche Ltd.
• Medtronic
• Thermo Fisher Scientific Inc.
• Siemens Healthcare

 Key Data Points Covered in the Report

The report covers exhaustive analysis on:

• Automatic Clotting Timer Systems Market by product type, technology, application, end user and region
• Regional level market analysis of North America, Latin America, Europe, Asia Pacific Excluding Japan, Japan, Middle East & Africa by test type, end user segments and country
• Automatic Clotting Timer Systems Market Dynamics & Opportunity Assessment
• Historical Actual Market Size, 2013 - 2017
• Automatic Clotting Timer Systems Market Size & Forecast 2018 - 2028
• Automatic Clotting Timer Systems Agents Current Trends/Issues/Challenges
• Competition & Companies involved

Research Methodology

The market sizing of automatic clotting timer systems will be done by the adoption data triangulation approach, which is primarily based on experimental techniques, such as patient-level data, to obtain precise market estimations and insights on Molecule and Drug Classes, API Formulations and preferred modes of administration. Bottom-up approach is always used to obtain insightful data for the specific countries/regions. The country-specific data is again analyzed to derive data at a global level. This methodology ensures high-quality and accuracy of information.

Secondary research will be used at the initial phase to identify the age-specific disease epidemiology, diagnosis rate and treatment pattern, as per disease indications. Each piece of information will be eventually analyzed during the entire research project, which will help build a strong base for the primary research information.

Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, nursing managers, clinical specialists who provide valuable insights on trends and clinical application of the drugs, key treatment patterns, adoption rate, and compliance rate.

Market Segmentation

By Product type

• Point of Care
• Clinical laboratory analyzer

By Application

• Cardiovascular and vascular surgery
• ECMO
• Cardiac catheterization laboratories
• Critical care units
• Hemodialysis units

By Technology

• Optical detection
• Laser based detection
• Mechanical detection
• Fluorescent based detection

By End user

• Hospitals
• Clinical Laboratories
• Ambulatory surgical centers
• Academic & research Institutes

By Region

• North America
• Latin America
• Europe
• Asia Pacific Excluding Japan
• Japan
• Middle East & Africa